Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Cerevel Therapeutics Holdings, Inc. (CERE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/12/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/11/2023 8-K Quarterly results
10/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/07/2023 4 Renaud Ronald C JR (President & CEO) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Bought 83,857 shares @ $23.9552, valued at $2M
08/07/2023 4 Burgess Paul D. (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Bought 21,880 shares @ $22.9339, valued at $501.8k
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/13/2023 4 COLES N ANTHONY (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 50,000 shares @ $30.0268, valued at $1.5M
Exercised 50,000 options to buy @ $3.5, valued at $175k
07/11/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 4 Burgess Paul D. (See Remarks) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 95,931 options to buy @ $31.45, valued at $3M
Granted 23,847 restricted stock units @ $0
06/28/2023 3 Burgess Paul D. (See Remarks) has filed a Form 3 on Cerevel Therapeutics Holdings, Inc.
06/12/2023 4 BAIN CAPITAL INVESTORS LLC (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Disposed of 432,627 shares @ $0
06/09/2023 4 Gordon Christopher R (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Disposed of 432,627 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/09/2023 4 Koppel Adam (10% Owner) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Disposed of 432,627 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/09/2023 4 Sulzberger Gabrielle (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/09/2023 4 Giordano Douglas E. (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/09/2023 4 Mckernan Ruth (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/09/2023 4 PATRICK DEVAL L (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/09/2023 4 RIEDEL NORBERT G (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/09/2023 4 DEKKERS MARIJN E (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 3,282 shares @ $0
Granted 13,780 options to buy @ $32.6, valued at $449.2k
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 3 ALTSCHULLER Susan (CFO) has filed a Form 3 on Cerevel Therapeutics Holdings, Inc.
05/19/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
05/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer"
05/08/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
05/08/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 4 COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 37,568 shares @ $31.3636, valued at $1.2M
Sold 12,132 shares @ $31.7579, valued at $385.3k
Sold 300 shares @ $32.93, valued at $9.9k
Exercised 50,000 options to buy @ $3.5, valued at $175k
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 144 Form 144 - Report of proposed sale of securities:
05/03/2023 8-K Quarterly results
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy